• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与左侧心力衰竭相关的肺动脉高压。

Pulmonary hypertension associated with left-sided heart failure.

机构信息

Clinic III for Internal Medicine, Heart Center at the University of Cologne.

Cologne Cardiovascular Research Center (CCRC), University of Cologne, Cologne, Germany.

出版信息

Curr Opin Cardiol. 2020 Nov;35(6):610-619. doi: 10.1097/HCO.0000000000000791.

DOI:10.1097/HCO.0000000000000791
PMID:32969856
Abstract

PURPOSE OF REVIEW

Pulmonary hypertension is a common phenomenon in heart failure patients that is highly relevant for morbidity and outcome. Although postcapillary in nature, the pathophysiology of pulmonary hypertension in patients with heart failure with reduced or preserved ejection fraction is complex, and decisions about management strategies remain challenging.

RECENT FINDINGS

Recently, the hemodynamic definitions and subclassification of postcapillary pulmonary hypertension have been revisited. The distinction between isolated postcapillary pulmonary hypertension (IpcPH) and combined post and precapillary pulmonary hypertension (CpcPH) and their definition are essential. Novel data on the prognostic impact of hemodynamic variables and right ventricular function highlight the importance of cardiopulmonary interaction in patients with left-sided heart failure (LHF). Furthermore, the impact of management strategies including medical therapy, remote hemodynamic monitoring, and interventional approaches on hemodynamics and outcome has recently been investigated. Here, we critically review recent developments and future considerations in this field, and highlight distinct treatment strategies targeting the underlying left heart condition, the pulmonary circulation, and/or impaired right ventricular function.

SUMMARY

Detailed hemodynamic characterization and proper phenotyping are essential for prognostication and the management of patients with pulmonary hypertension associated with LHF, both in clinical practice and when addressing research questions.

摘要

目的综述

肺动脉高压是心力衰竭患者的一种常见现象,与发病率和预后密切相关。尽管本质上是毛细血管后病变,但射血分数降低或保留的心力衰竭患者的肺动脉高压病理生理学较为复杂,管理策略的决策仍然具有挑战性。

最近发现

最近,毛细血管后肺动脉高压的血流动力学定义和亚分类已经重新审视。孤立性毛细血管后肺动脉高压(IpcPH)和合并毛细血管后和前毛细血管肺动脉高压(CpcPH)的区分及其定义至关重要。血流动力学变量和右心室功能的预后影响的新数据突出了左心衰竭(LHF)患者中心肺相互作用的重要性。此外,最近还研究了包括药物治疗、远程血流动力学监测和介入方法在内的管理策略对血流动力学和预后的影响。在此,我们批判性地回顾了该领域的最新进展和未来考虑因素,并强调了针对潜在左心疾病、肺循环和/或受损右心室功能的不同治疗策略。

总结

详细的血流动力学特征描述和恰当的表型分析对于预测和管理与 LHF 相关的肺动脉高压至关重要,无论是在临床实践中还是在解决研究问题时都是如此。

相似文献

1
Pulmonary hypertension associated with left-sided heart failure.与左侧心力衰竭相关的肺动脉高压。
Curr Opin Cardiol. 2020 Nov;35(6):610-619. doi: 10.1097/HCO.0000000000000791.
2
Pulmonary hypertension associated with left heart disease.与左心疾病相关的肺动脉高压。
Herz. 2023 Aug;48(4):266-273. doi: 10.1007/s00059-023-05189-z. Epub 2023 Jun 8.
3
[Pulmonary hypertension associated with left heart disease (group 2)].[与左心疾病相关的肺动脉高压(第2组)]
Dtsch Med Wochenschr. 2023 Nov;148(23):1498-1506. doi: 10.1055/a-2012-0803. Epub 2023 Nov 10.
4
Left ventricular heart failure and pulmonary hypertension.左心室心力衰竭和肺动脉高压。
Eur Heart J. 2016 Mar 21;37(12):942-54. doi: 10.1093/eurheartj/ehv512. Epub 2015 Oct 27.
5
Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.缺血性心力衰竭的肺血管机械性后果及其对右心室功能的影响。
Am J Physiol Heart Circ Physiol. 2019 May 1;316(5):H1167-H1177. doi: 10.1152/ajpheart.00319.2018. Epub 2019 Feb 15.
6
Pulmonary hypertension in HFpEF and HFrEF: Pathophysiology, diagnosis, treatment approaches.射血分数保留的心力衰竭和射血分数降低的心力衰竭中的肺动脉高压:病理生理学、诊断、治疗方法
Herz. 2019 Sep;44(6):483-490. doi: 10.1007/s00059-019-4831-6.
7
Update in approaches to pulmonary hypertension because of left heart disease.左心疾病相关肺动脉高压治疗方法的新进展。
Curr Opin Pulm Med. 2022 Sep 1;28(5):337-342. doi: 10.1097/MCP.0000000000000891. Epub 2022 Jul 16.
8
Pulmonary Hypertension Due to Left Heart Disease-A Practical Approach to Diagnosis and Management.左心疾病所致肺动脉高压的诊断与处理策略
Can J Cardiol. 2021 Apr;37(4):572-584. doi: 10.1016/j.cjca.2020.11.003. Epub 2020 Nov 17.
9
Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.左心衰竭中肺动脉高压的血流动力学表型分析
Circ Heart Fail. 2017 Sep;10(9). doi: 10.1161/CIRCHEARTFAILURE.117.004082.
10
[2022 ESC/ERS guidelines on the diagnostics and treatment of pulmonary hypertension : A focussed review].[2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南:重点综述]
Herz. 2023 Feb;48(1):23-30. doi: 10.1007/s00059-022-05155-1. Epub 2023 Jan 17.

引用本文的文献

1
Echocardiographic Insights into Group 2 Pulmonary Hypertension: Unveiling its Prevalence in Advanced Heart Failure Reduced Ejection Fraction.超声心动图对2型肺动脉高压的见解:揭示其在射血分数降低的晚期心力衰竭中的患病率。
J Cardiovasc Echogr. 2025 Apr-Jun;35(2):142-148. doi: 10.4103/jcecho.jcecho_91_24. Epub 2025 Jul 30.
2
miR-135b: An emerging player in cardio-cerebrovascular diseases.微小RNA-135b:心脑血管疾病中的一个新角色。
J Pharm Anal. 2024 Oct;14(10):100997. doi: 10.1016/j.jpha.2024.100997. Epub 2024 May 8.
3
Editorial: Advances in understanding the mechanisms of pulmonary hypertension.
社论:肺动脉高压发病机制研究进展
Front Cardiovasc Med. 2023 Sep 15;10:1249889. doi: 10.3389/fcvm.2023.1249889. eCollection 2023.
4
Sotatercept analog improves cardiopulmonary remodeling and pulmonary hypertension in experimental left heart failure.索他西普类似物可改善实验性左心衰竭中的心肺重塑和肺动脉高压。
Front Cardiovasc Med. 2023 Feb 23;10:1064290. doi: 10.3389/fcvm.2023.1064290. eCollection 2023.
5
Impaired cell-cell communication and axon guidance because of pulmonary hypoperfusion during postnatal alveolar development.由于出生后肺泡发育过程中的肺低灌注导致细胞-细胞通讯和轴突导向受损。
Respir Res. 2023 Jan 11;24(1):12. doi: 10.1186/s12931-023-02319-3.
6
Decreased Peak Left Atrial Longitudinal Strain Is Associated with Persistent Pulmonary Hypertension Associated with Left Heart Disease.左心房纵向应变峰值降低与左心疾病相关的持续性肺动脉高压有关。
J Clin Med. 2022 Jun 18;11(12):3510. doi: 10.3390/jcm11123510.
7
Effects of Metoprolol Succinate Combined with Entresto on Cardiac Function Indexes and Coagulation Function in Patients with Congestive Heart Failure.琥珀酸美托洛尔缓释片联合恩格列净对充血性心力衰竭患者心功能指标及凝血功能的影响。
Comput Math Methods Med. 2022 May 21;2022:9765884. doi: 10.1155/2022/9765884. eCollection 2022.
8
Novel Prognostic Predictor for Primary Pulmonary Hypertension: Focus on Blood Urea Nitrogen.原发性肺动脉高压的新型预后预测指标:聚焦血尿素氮
Front Cardiovasc Med. 2021 Oct 25;8:724179. doi: 10.3389/fcvm.2021.724179. eCollection 2021.
9
PTEN as a Therapeutic Target in Pulmonary Hypertension Secondary to Left-heart Failure: Effect of HO-3867 and Supplemental Oxygenation.PTEN 在左心衰竭性肺动脉高压中的治疗靶点:HO-3867 和补充氧疗的作用。
Cell Biochem Biophys. 2021 Sep;79(3):593-607. doi: 10.1007/s12013-021-01010-y. Epub 2021 Jun 16.